EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intermittent administration of PTH for the treatment of inflammatory bone loss does not enhance entheseal pathological new bone formation

Shuai Zhang, Wenjun Hao, Dongying Chen, Siwen Chen, Zihao Li, Fangling Zhong, Haitao Wang, Jianru Wang, Zhaomin Zheng, Zhongping Zhan, Guo Dai, Hui Liu

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.149888 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Shuai Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China; Guangdong Province Key Labor…. Hauptthemen laut MEDLINE: Parathyroid Hormone, Osteogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate the effect of intermittent parathyroid hormone (iPTH) administration on pathological new bone formation during treatment of ankylosing spondylitis-related osteoporosis. METHODS: Animal models with pathological bone formation caused by hypothetical AS pathogenesis received treatment with iPTH. We determined the effects of iPTH on bone loss and the formation of pathological new bone with micro-computed tomography (micro-CT) and histological examination. In addition, the tamoxifen-inducible conditional knockout mice (CAGGCre-ERTM; PTHflox/flox, PTH-/-) was established to delete PTH and investigate the effect of endogenous PTH on pathological new bone formation. RESULTS: iPTH treatment significantly improved trabecular bone mass in the modified collagen-induced arthritis (m-CIA) model and unbalanced mechanical loading models. Meanwhile, iPTH treatment did not enhance pathological new bone formation in all types of animal models. Endogenous PTH deficiency had no effects on pathological new bone formation in unbalanced mechanical loading models. CONCLUSION: Experimental animal models of AS treated with iPTH show improvement in trabecular bone density, but not entheseal pathological bone formation,indicating it may be a potential treatment for inflammatory bone loss does in AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parathyroid HormoneOsteogenesisAnimalsMiceOsteoporosisMice, KnockoutMaleX-Ray MicrotomographySpondylitis, AnkylosingMice, Inbred C57BLDisease Models, AnimalArthritis, ExperimentalBone Density

Stichwörter der Autor:innen

Ankylosing spondylitisEndochondral ossificationOsteoporosisParathyroid hormonePathological new bone formation

Substanzen

Parathyroid Hormone

Autor:innen und Institutionen

  • Department of Spine Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China; Guangdong Province Key Laboratory of Orthopaedics and Traumatology, Guangzhou, 510080, Guangdong,…
  • Department of Rheumatology and Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, S., Hao, W., Chen, D., Chen, S., Li, Z., Zhong, F., Wang, H., Wang, J., Zheng, Z., Zhan, Z., Dai, G., & Liu, H. (2024). Intermittent administration of PTH for the treatment of inflammatory bone loss does not enhance entheseal pathological new bone formation. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.149888

Vancouver

Zhang S, Hao W, Chen D, Chen S, Li Z, Zhong F, et al. Intermittent administration of PTH for the treatment of inflammatory bone loss does not enhance entheseal pathological new bone formation. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.149888

BibTeX
@article{Zhang2024,
  author = {Zhang, Shuai and Hao, Wenjun and Chen, Dongying and Chen, Siwen and Li, Zihao and Zhong, Fangling and Wang, Haitao and Wang, Jianru and Zheng, Zhaomin and Zhan, Zhongping and Dai, Guo and Liu, Hui},
  title = {Intermittent administration of PTH for the treatment of inflammatory bone loss does not enhance entheseal pathological new bone formation},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.149888}
}
Kostenlos starten →